Impact of cephalosporin restriction on incidence of infections with extended-spectrum beta-lactamase-producing Klebsiella pneumoniae in an endemic setting

References

• Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, de Cueto M, Gálvez J, et al. Risk-factors for emerging bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli. Clin Microbiol Infect. 2008;14(2):180–3.10.1111/j.1469-0691.2007.01884.x
   PubMed Web of Science ®Google Scholar
• Chopra T, Marchaim D, Johnson PC, Chalana IK, Tamam Z, Mohammed M, et al. Risk factors for bloodstream infection caused by extended-spectrum β-lactamase–producing Escherichia coli and Klebsiella pneumoniae: a focus on antimicrobials including cefepime. Am J Infect Control. 2015;43(7):719–23.10.1016/j.ajic.2015.02.030
   PubMed Web of Science ®Google Scholar
• Wu U-I, Yang C-S, Chen W-C, Chen Y-C, Chang S-C. Risk factors for bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli. J Microbiol Immunol Infect. 2010;43(4):310–6.10.1016/S1684-1182(10)60048-5
   PubMedGoogle Scholar
• Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, et al. Community-onset bacteremia due to extended-spectrum β-lactamase–producing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010;50(1):40–8.10.1086/648976
   PubMed Web of Science ®Google Scholar
• Mosqueda-Gómez JL, Montaño-Loza A, Rolón AL, Cervantes C, Bobadilla-del-Valle JM, Silva-Sánchez J, et al. Molecular epidemiology and risk factors of bloodstream infections caused by extended-spectrum β-lactamase-producing Klebsiella pneumoniae. Int J Infect Dis. 2008;12(6):653–9.10.1016/j.ijid.2008.03.008
   PubMed Web of Science ®Google Scholar
• Urbánek K, Kolár M, Lovecková Y, Strojil J, Santavá L. Influence of third-generation cephalosporin utilization on the occurrence of ESBL-positive Klebsiella pneumoniae strains. J Clin Pharm Ther. 2007;32(4):403–8.10.1111/jcp.2007.32.issue-4
   PubMed Web of Science ®Google Scholar
• Rahal JJ, Urban C, Horn D, Freeman K, Segal-Maurer S, Maurer J, et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial klebsiella. JAMA. 1998;280(14):1233–1237.10.1001/jama.280.14.1233
   PubMed Web of Science ®Google Scholar
• Lee S, Lee ES, Park SY, Kim S, Seo Y, Cho YK. Reduced use of third-generation cephalosporins decreases the acquisition of extended-spectrum beta-lactamase–producing Klebsiella pneumoniae. Infect Control Hosp Epidemiol. 2004;25(10):832–7.10.1086/502304
   PubMed Web of Science ®Google Scholar
• Andersen SE, Knudsen JD. For the Bispebjerg Intervention Group a managed multidisciplinary programme on multi-resistant Klebsiella pneumoniae in a Danish University Hospital. BMJ Qual Saf. 2013;22(11):907–15.10.1136/bmjqs-2012-001791
   PubMed Web of Science ®Google Scholar
• Knudsen JD, Andersen SE. For the Bispebjerg Intervention Group. A multidisciplinary intervention to reduce infections of ESBL- and AmpC-producing, gram-negative bacteria at a University Hospital. In Wu M, editor. PLoS ONE; 2014. Vol. 9. p. e86457.
   PubMed Web of Science ®Google Scholar
• Oliveira P, Paula A, Dal-Paz K, Felix C, Rossi F, Silva J, et al. Impact of restriction of cefepime use on the antimicrobial susceptibility of Gram-negative bacilli related to healthcare-associated infections in an orthopedic hospital. Infect Drug Resist. 2011;4:149.
   PubMedGoogle Scholar
• Antoniadou A, Kanellakopoulou K, Kanellopoulou M, Polemis M, Koratzanis G, Papademetriou E, et al. Impact of a hospital-wide antibiotic restriction policy program on the resistance rates of nosocomial Gram-negative bacteria. Scand J Infect Dis. 2013;45(6):438–45.10.3109/00365548.2012.760845
   PubMed Web of Science ®Google Scholar
• Tangden T, Eriksson B-M, Melhus A, Svennblad B, Cars O. Radical reduction of cephalosporin use at a tertiary hospital after educational antibiotic intervention during an outbreak of extended-spectrum -lactamase-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2011;66(5):1161–7.10.1093/jac/dkr053
   PubMed Web of Science ®Google Scholar
• WHO. ATC/DDD index 2016. [Internet]. [cited 2016 Jan 13]. Available from: http://www.whocc.no/atc_ddd_index/
   Google Scholar
• WHO. DDD. Definition and general considerations. [Internet]. [cited 2016 Jan 13]. Available from: http://www.whocc.no/ddd/definition_and_general_considera/
   Google Scholar
• European Centre for Disease Prevention and Control. Antimicrobial resistance surveillance in Europe 2010. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net). ECDC; 2011.
   Google Scholar
• Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309.10.1046/j.1365-2710.2002.00430.x
   PubMed Web of Science ®Google Scholar
• Davey P, Brown E, Charani E, Fenelon L, Gould IM, Holmes A, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. In The Cochrane Collaboration, editor. Cochrane database of systematic reviews [Internet]. Chichester: Wiley; 2013. [cited 2016 Jan 14]. Available from: http://doi.wiley.com/10.1002/14651858.CD003543.pub3
   Web of Science ®Google Scholar
• Wener KM, Schechner V, Gold HS, Wright SB, Carmeli Y. Treatment with fluoroquinolones or with -lactam- -lactamase inhibitor combinations is a risk factor for isolation of extended-spectrum- -lactamase-producing klebsiella species in hospitalized patients. Antimicrob Agents Chemother. 2010;54(5):2010–6.10.1128/AAC.01131-09
   PubMed Web of Science ®Google Scholar
• Harris AD, McGregor JC, Johnson JA, Strauss SM, Moore AC, Standiford HC, et al. Risk factors for colonization with extended-spectrum β-lactamase–producing bacteria and intensive care unit admission. Emerg Infect Dis. 2007;13(8):1144.10.3201/eid1308.070071
   PubMed Web of Science ®Google Scholar
• Søraas A, Sundsfjord A, Sandven I, Brunborg C, Jenum PA. Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae –a case–control study in a low prevalence country. In Kluytmans J, editor. PLoS ONE; 2013. Vol. 8. p. e69581.
   PubMed Web of Science ®Google Scholar
• Sarma JB, Marshall B, Cleeve V, Tate D, Oswald T, Woolfrey S. Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis. J Hosp Infect. 2015;91(1):68–73.10.1016/j.jhin.2015.05.006
   PubMed Web of Science ®Google Scholar
• Verlinden A, Jansens H, Goossens H, van de Velde AL, Schroyens WA, Berneman ZN, et al. Clinical and microbiological impact of discontinuation of fluoroquinolone prophylaxis in patients with prolonged profound neutropenia. Eur J Haematol. 2014;93(4):302–8.10.1111/ejh.2014.93.issue-4
   PubMed Web of Science ®Google Scholar
• Lee J, Oh CE, Choi EH, Lee HJ. The impact of the increased use of piperacillin/tazobactam on the selection of antibiotic resistance among invasive Escherichia coli and Klebsiella pneumoniae isolates. Int J Infect Dis. 2013;17(8):e638–43.10.1016/j.ijid.2013.01.030
   PubMed Web of Science ®Google Scholar
• Damjanova I, Tóth A, Pászti J, Hajbel-Vékony G, Jakab M, Berta J, et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005–the new ‘MRSAs’? J Antimicrob Chemother. 2008;62(5):978–85.10.1093/jac/dkn287
   PubMed Web of Science ®Google Scholar
• Tacconelli E, Cataldo MA, Dancer SJ, De Angelis G, Falcone M, Frank U, et al. ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. Clin Microbiol Infect. 2014;20:1–55.10.1111/1469-0691.12427
   PubMed Web of Science ®Google Scholar
• van Assen MALM, van Aert RCM, Nuijten MB, Wicherts JM. Why publishing everything is more effective than selective publishing of statistically significant results. In Wray KB, editor. PLoS ONE; 2014. Vol. 9. p. e84896.
   PubMed Web of Science ®Google Scholar